Task A53: High Throughput Evaluation of COVID-19 Therapeutics in Small Animal Models
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 272201700041I-0-759302100002-1
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$379,235Funder
National Institutes of Health (NIH)Principal Investigator
Unspecified Bart TarbetResearch Location
United States of AmericaLead Research Institution
Utah State UniversityResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Disease models
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This contract provides for the development and standardization of small animal models of infectious diseases, and may include efficacy testing of candidate products, including GLP studies to support licensure.